SIMONE, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 3.297
AS - Asia 1.357
EU - Europa 1.059
SA - Sud America 250
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.046
Nazione #
US - Stati Uniti d'America 3.220
SG - Singapore 524
CN - Cina 309
IT - Italia 303
BR - Brasile 186
RU - Federazione Russa 170
SE - Svezia 151
HK - Hong Kong 139
VN - Vietnam 104
DE - Germania 89
FR - Francia 82
BD - Bangladesh 74
GB - Regno Unito 73
FI - Finlandia 49
CA - Canada 44
IN - India 39
CI - Costa d'Avorio 29
AR - Argentina 26
ID - Indonesia 26
NL - Olanda 26
UA - Ucraina 21
PL - Polonia 20
IQ - Iraq 19
BE - Belgio 18
TR - Turchia 18
JP - Giappone 17
MX - Messico 17
PK - Pakistan 16
SA - Arabia Saudita 14
ZA - Sudafrica 14
PH - Filippine 13
AT - Austria 10
EC - Ecuador 10
EG - Egitto 8
ES - Italia 8
TN - Tunisia 8
UZ - Uzbekistan 8
VE - Venezuela 8
CO - Colombia 7
CZ - Repubblica Ceca 7
JO - Giordania 7
LT - Lituania 7
MA - Marocco 6
NP - Nepal 5
BO - Bolivia 4
IE - Irlanda 4
KE - Kenya 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
PS - Palestinian Territory 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MZ - Mozambico 2
PA - Panama 2
PY - Paraguay 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
ME - Montenegro 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.046
Città #
Ashburn 364
Fairfield 329
Singapore 280
Chandler 240
San Jose 214
Woodbridge 185
Houston 177
Hong Kong 139
Seattle 134
Nyköping 126
Beijing 124
Cambridge 124
Wilmington 121
Bari 112
Ann Arbor 80
Los Angeles 79
Dallas 54
Chicago 49
New York 44
Lauterbourg 41
Council Bluffs 38
Lawrence 36
Buffalo 35
Jacksonville 33
Roxbury 31
Abidjan 29
Helsinki 28
Moscow 27
Ho Chi Minh City 24
Salt Lake City 24
Santa Clara 24
Frankfurt am Main 23
Des Moines 22
Inglewood 22
Dong Ket 21
Jakarta 21
Boardman 20
Brooklyn 19
São Paulo 19
Brussels 18
Hanoi 17
Nanjing 17
Milan 16
Montreal 16
Munich 15
Imbersago 14
San Diego 13
Tampa 13
Toronto 13
Warsaw 13
Amsterdam 12
Elk Grove Village 12
Paris 12
Princeton 12
Rome 12
The Dalles 12
Tokyo 12
Atlanta 11
Falls Church 11
Poplar 11
Cagliari 10
Denver 10
Falkenstein 10
Rio de Janeiro 10
Columbus 9
Dearborn 9
Nuremberg 9
Orem 9
Johannesburg 8
Miami 8
Mottola 8
Norwalk 8
San Francisco 8
Shenyang 8
Tashkent 8
Turku 8
Baghdad 7
Hebei 7
London 7
Manchester 7
New Delhi 7
North Bergen 7
Shanghai 7
Washington 7
Amman 6
Belo Horizonte 6
Brno 6
Haiphong 6
Mexico City 6
Phoenix 6
Stockholm 6
Boston 5
Cairo 5
Cardiff 5
Chennai 5
Guangzhou 5
Jeddah 5
Jiaxing 5
Kansas City 5
Pune 5
Totale 4.077
Nome #
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 275
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 243
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 233
Antibasal Ganglia Antibodies and Antistreptolysin O in Noncomorbid ADHD 199
Overlap Between Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder: Searching for Distinctive/Common Clinical Features 185
Prognostic indicators in pediatric clinically isolated syndrome 180
Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial 179
Markers of neurodevelopmental impairments in early-onset psychosis 173
Non-Verbal Cognitive Abilities in Children and Adolescents Affected by Migraine and Tension-Type Headache: An Observational Study Using the Leiter-3 166
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis 163
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 155
Autism spectrum disorders in XYY syndrome: two new cases and systematic review of the literature. 148
Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents 142
KIF5A and ALS2 Variants in a Family With Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis 134
Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder 133
Intelligence and controls of the emotions: a new test for the evaluation of the emotional responsivity 132
Multiple Sclerosis Progression and Relapse Activity in Children 131
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study. 128
B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder 127
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 126
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 126
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 123
Use of Disease-Modifying Therapies in Pediatric MS 115
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 115
Autism spectrum disorder and duchenne muscular dystrophy: A clinical case on the potential role of the dystrophin in autism neurobiology 115
Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders 111
Association between MRI structural features and cognitive measures in pediatric multiple sclerosis 103
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: A case report of a childhood multiple sclerosis 99
A Randomized Computer-Assisted Rehabilitation Trial of Attention in Pediatric Multiple Sclerosis: A Post Hoc Analysis 99
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients 97
null 96
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 92
null 91
null 91
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis 89
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 89
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort 87
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression 78
null 77
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: A case report of a childhood multiple sclerosis. 74
Psychological impact of the SARS-CoV-2 pandemic in children with neurodevelopmental disorders and their families: Evaluation before and during covid-19 outbreak among an Italian sample 74
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis 73
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes 73
Coping, stress and negative psychological outcomes in parents of children admitted to a pediatric neurorehabilitation care unit 69
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy 66
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 66
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis 65
Complessità dei disturbi dell'apprendimento:studio di un campione di soggetti affetti 65
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study 63
Peripheral Iron Levels in Autism Spectrum Disorders vs. Other Neurodevelopmental Disorders: Preliminary Data 58
Neuropsychopathological comorbidities in learning disorders. 47
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years 41
A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis 36
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 31
Clinical phenotype of the 16p.13.11 microdeletion: a case report with a mini review of the literature 25
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006) 25
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 24
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients 23
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis 22
null 21
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis 20
Refining Prognostic Factors in Adult-Onset Multiple Sclerosis: A Narrative Review of Current Insights 18
Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study 17
Selective Plasmatic Amino Acid Alterations as a Potential Biomarker for Pathological Stratification in Autism Spectrum Disorders 3
Totale 6.344
Categoria #
all - tutte 26.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022356 23 19 8 7 11 37 21 24 31 37 51 87
2022/2023524 64 74 47 46 43 73 9 77 59 1 19 12
2023/2024214 16 32 13 17 15 48 18 15 4 14 2 20
2024/20251.152 42 14 63 39 31 105 131 108 37 64 275 243
2025/20262.376 310 113 142 185 319 156 272 76 335 318 95 55
Totale 6.344